As of 2024-07-27, the Relative Valuation of FibroGen Inc (FGEN) is (74.87) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.16 USD, the upside of FibroGen Inc based on Relative Valuation is -6554.6%.
The range of the Relative Valuation is (74.45) - (75.42) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 30.8x - 31.8x | 31.3x |
| Forward P/E multiples | 30.1x - 31.2x | 30.6x |
| Fair Price | (74.45) - (75.42) | (74.87) |
| Upside | -6518.1% - -6601.5% | -6554.6% |
| Date | P/E |
| 2024-07-26 | -0.48 |
| 2024-07-25 | -0.51 |
| 2024-07-24 | -0.52 |
| 2024-07-23 | -0.51 |
| 2024-07-22 | -0.52 |
| 2024-07-19 | -0.43 |
| 2024-07-18 | -0.43 |
| 2024-07-17 | -0.44 |
| 2024-07-16 | -0.47 |
| 2024-07-15 | -0.44 |
| 2024-07-12 | -0.43 |
| 2024-07-11 | -0.41 |
| 2024-07-10 | -0.37 |
| 2024-07-09 | -0.35 |
| 2024-07-08 | -0.33 |
| 2024-07-05 | -0.30 |
| 2024-07-03 | -0.29 |
| 2024-07-02 | -0.31 |
| 2024-07-01 | -0.32 |
| 2024-06-28 | -0.37 |
| 2024-06-27 | -0.43 |
| 2024-06-26 | -0.44 |
| 2024-06-25 | -0.48 |
| 2024-06-24 | -0.50 |
| 2024-06-21 | -0.47 |
| 2024-06-20 | -0.46 |
| 2024-06-18 | -0.43 |
| 2024-06-17 | -0.44 |
| 2024-06-14 | -0.46 |
| 2024-06-13 | -0.48 |
| 2024-06-12 | -0.48 |
| 2024-06-11 | -0.47 |
| 2024-06-10 | -0.47 |
| 2024-06-07 | -0.46 |
| 2024-06-06 | -0.49 |
| 2024-06-05 | -0.50 |
| 2024-06-04 | -0.49 |
| 2024-06-03 | -0.51 |
| 2024-05-31 | -0.50 |
| 2024-05-30 | -0.48 |
| 2024-05-29 | -0.48 |
| 2024-05-28 | -0.53 |
| 2024-05-24 | -0.54 |
| 2024-05-23 | -0.53 |
| 2024-05-22 | -0.51 |
| 2024-05-21 | -0.49 |
| 2024-05-20 | -0.50 |
| 2024-05-17 | -0.50 |
| 2024-05-16 | -0.51 |
| 2024-05-15 | -0.49 |